A new $4.9 million grant has been awarded to the Perelman School of Medicine at the University of Pennsylvania to use behavioral economics and implementation science to improve the uptake of evidence-based practices in cancer care. Penn Center for Cancer Care Innovation (PC3I) Director Justin E. Bekelman, MD, will serve as one of three principal investigators (PIs) leading this project along with PC3I Advisory Group members Rinad Beidas, PhD, and Robert A. Schnoll, PhD. The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is funding the work through a P50 grant over five years. The award, part of the Cancer Moonshot Initiative, makes Penn one of seven centers across the country working on this effort as part of the NCI’s Implementation Science Centers in Cancer Control.
The team, which brings together experts from across Penn, also includes PC3I Faculty Katharine Rendle, PhD, MSW, MPH; Samuel Takvorian, MD, MS; and Peter Gabriel, MD, MSE; as well as PC3I Affiliates David Asch, MD, MBA; Frances Barg, PhD, MEd; Frank Leone, MD, MS; and Brian Jenssen, MD, MSHP; Mitesh Patel, MD, MBA, MS; Karen Glanz, PhD, MPH; Carmen Guerra, MD, MSCE; Katharine Nathanson, MD; Roy Rosin, MBA; and Kevin Volpp, MD, PhD.
For more information, click here to read the Penn Medicine press release.
Despite known screening and diagnosis delays, PC3I finds the pandemic was not associated with treatment initiation delays or changes for patients with newly-diagnosed advanced cancer.
The National Comprehensive Cancer Network (NCCN) Oncology Research Program has awarded funding to a PC3I team to improve patient care and outcomes in early-stage NSCLC.
PC3I is pleased to share our 2020-2021 Impact Report, which shares highlights from our work over the past year to create, test, and scale solutions to some of the most intractable problems in cancer care delivery.